Takeda Pharmaceutical (TAK) Insider Trading & Ownership $15.05 +0.04 (+0.27%) Closing price 03:58 PM EasternExtended Trading$15.08 +0.04 (+0.23%) As of 05:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Takeda Pharmaceutical (NYSE:TAK) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.04%Number OfInsiders Buying(Last 3 Years)0Number OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$30.00 M Get TAK Insider Trade Alerts Want to know when executives and insiders are buying or selling Takeda Pharmaceutical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TAK Insider Buying and Selling by Quarter Remove Ads Takeda Pharmaceutical Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/24/2024Pharmaceutical Co Ltd TakedaMajor ShareholderSell3,703,703$8.10$29,999,994.30 (Data available from 1/1/2013 forward) TAK Insider Trading Activity - Frequently Asked Questions Who is on Takeda Pharmaceutical's Insider Roster? The list of insiders at Takeda Pharmaceutical includes Pharmaceutical Co Ltd Takeda. Learn more on insiders at TAK. What percentage of Takeda Pharmaceutical stock is owned by insiders? 0.04% of Takeda Pharmaceutical stock is owned by insiders. Learn more on TAK's insider holdings. Which Takeda Pharmaceutical insiders have been selling company stock? The following insider sold TAK shares in the last 24 months: Pharmaceutical Co Ltd Takeda ($29,999,994.30). How much insider selling is happening at Takeda Pharmaceutical? Insiders have sold a total of 3,703,703 Takeda Pharmaceutical shares in the last 24 months for a total of $29,999,994.30 sold. Takeda Pharmaceutical Key ExecutivesMr. Christophe Weber (Age 58)President, CEO & Representative Director Compensation: $3.74MDr. Andrew S. Plump (Age 59)President of Research & Development and Representative Director Compensation: $2.67MDr. Seigo IzumoChair of Management BoardMr. Milano Furuta (Age 46)Chief Financial Officer Mr. Haruhiko Hirate (Age 67)Member of Management Board Mr. Salvatore Alesci M.D. (Age 49)Ph.D., Member of Management Board and Head of R&D Global Science & Biomedical Policy Norimasa TakedaChief Accounting Officer & Corporate ControllerMr. Iwaaki TaniguchiSenior Vice President of Corporate Finance & Controlling DepartmentMr. Gabriele Ricci (Age 46)Chief Data & Technology Officer Mr. Christopher David O'ReillyGlobal Head of Investor Relations & Global Finance More Insider Trading Tools from MarketBeat Related Companies Sanofi Insider Ownership GSK Insider Ownership argenx Insider Ownership Beigene Insider Ownership BioNTech Insider Ownership Teva Pharmaceutical Industries Insider Ownership Summit Therapeutics Insider Ownership Intra-Cellular Therapies Insider Ownership Genmab A/S Insider Ownership Moderna Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles NVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It Matters This page (NYSE:TAK) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Takeda Pharmaceutical Company Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Takeda Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TAK Stock Free TAK Stock Alerts